Valirx Plc operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Valirx Plc with three other
companies in this sector in the United Kingdom:
Tissue Regenix Group PLC
sales of £100,000.00 [US$132,450.00 ]
of which 72%
was Wound Care),
(£38,224.00 [US$50,627.69 ]
Reneuron Group PLC
(£30,000.00 [US$39,735.00 ]
of which 100%
was Cell-Based Therapies).
Valirx Plc reported sales of £82,603.00 (US$109.41 thousand)
December of 2015.
decrease of 5.7%
versus 2014, when the company's sales were £87,558.00 .